UGT1A1 Polymorphism Can Predict Hematologic Toxicity in Patients Treated with Irinotecan (Q58408313)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | UGT1A1 Polymorphism Can Predict Hematologic Toxicity in Patients Treated with Irinotecan |
article |
Statements
UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan (English)
Jean-François Côté
Sylvain Kirzin
Andrew Kramar
Jean-François Mosnier
Marie-Danièle Diebold
Isabelle Soubeyran
Anne-Sophie Thirouard